Related Experiment Video
Updated: Aug 2, 2026

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Interaction of metamizol with some hypnotics in rats
Abstract:
Metamizol (sodium N-(1,5-dimethyl-3-oxo-2-phenylpyrazolin-4-yl)-N-methylamino-methylsulphonate; Dipyrone) a non-narcotic analgesic was tested for hypnotic potentiating effect. Metamizol potentiated the hypnosis induced by pentobarbital, barbital and chloral hydrate. This effect was dose-dependent and was inversely proportional to the duration of the analgesic pretreatment. An augmented hypothermia and competition at drug metabolizing sites seem to be the mechanisms involved in the observed effect.
Insights
Metamizol, a non-narcotic analgesic, was found to enhance the hypnotic effects of several sedative drugs. This potentiation was dose-dependent and linked to increased hypothermia and potential competition for drug metabolism.
Area of Science:
- Pharmacology
- Neuroscience
Background:
- Metamizol (Dipyrone) is a widely used non-narcotic analgesic.
- Understanding drug interactions is crucial for patient safety and therapeutic efficacy.
Purpose of the Study:
- To investigate the hypnotic potentiating effects of Metamizol.
- To explore the underlying mechanisms of Metamizol's interaction with hypnotics.
Main Methods:
- Metamizol was administered to subjects prior to hypnotics like pentobarbital, barbital, and chloral hydrate.
- The hypnotic effects, duration, and body temperature were monitored.
- Dose-dependency and the influence of pretreatment duration were analyzed.
Main Results:
- Metamizol significantly potentiated the hypnosis induced by pentobarbital, barbital, and chloral hydrate.
- The observed potentiation was dose-dependent.
- The effect was inversely proportional to the duration of Metamizol pretreatment.
Conclusions:
- Metamizol exhibits a hypnotic potentiating effect on common sedatives.
- Augmented hypothermia and competition at drug-metabolizing sites are likely mechanisms.
- Further research into Metamizol's pharmacokinetic and pharmacodynamic interactions is warranted.
Related Concept Videos
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Management of Insomnia
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

